The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier

Jill A. Hoffman, Carol Wass, Monique Stins, Kwang Sik Kim

Research output: Contribution to journalArticle

Abstract

The vast majority of cases of gram-negative meningitis in neonates are caused by K1-encapsulated Escherichia coli. The role of the K1 capsule in the pathogenesis of E. coli meningitis was examined with an in vivo model of experimental hematogenous E. coli K1 meningitis and an in vitro model of the blood-brain barrier. Bacteremia was induced in neonatal rats with the E. coil K1 strain C5 (O18:K1) or its K1- derivative, C5ME. Subsequently, blood and cerebrospinal fluid (CSF) were obtained for culture. Viable bacteria were recovered from the CSF of animals infected with E. coli K1 strains only; none of the animals infected with K1- strains had positive CSF cultures. However, despite the fact that their cultures were sterile, the presence of O18 E. coil was demonstrated immunocytochemically in the brains of animals infected with K1- strains and was seen by staining of CSF samples. In vitro, brain microvascular endothelial cells (BMEC) were incubated with K1+ and K1- E. coli strains. The recovery of viable intracellular organisms of the K1+ strain was significantly higher than that for the K1- strain (P = 0.0005). The recovery of viable intracellular K1- E. coli bacteria was increased by cycloheximide treatment of BMEC (P = 0.0059) but was not affected by nitric oxide synthase inhibitors or oxygen radical scavengers. We conclude that the K1 capsule is not necessary for the invasion of bacteria into brain endothelial cells but is responsible for helping to maintain bacterial viability during invasion of the blood-brain barrier.

Original languageEnglish (US)
Pages (from-to)3566-3570
Number of pages5
JournalInfection and Immunity
Volume67
Issue number7
StatePublished - 1999
Externally publishedYes

Fingerprint

Blood-Brain Barrier
Capsules
Cerebrospinal Fluid
Escherichia coli Meningitis
Escherichia coli
Endothelial Cells
Brain
Bacteria
Microbial Viability
Cycloheximide
Bacteremia
Meningitis
Nitric Oxide Synthase
Reactive Oxygen Species
Theoretical Models
Staining and Labeling
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology

Cite this

The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. / Hoffman, Jill A.; Wass, Carol; Stins, Monique; Kim, Kwang Sik.

In: Infection and Immunity, Vol. 67, No. 7, 1999, p. 3566-3570.

Research output: Contribution to journalArticle

@article{1c486e853bf54e6593bd274c9f9089ff,
title = "The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier",
abstract = "The vast majority of cases of gram-negative meningitis in neonates are caused by K1-encapsulated Escherichia coli. The role of the K1 capsule in the pathogenesis of E. coli meningitis was examined with an in vivo model of experimental hematogenous E. coli K1 meningitis and an in vitro model of the blood-brain barrier. Bacteremia was induced in neonatal rats with the E. coil K1 strain C5 (O18:K1) or its K1- derivative, C5ME. Subsequently, blood and cerebrospinal fluid (CSF) were obtained for culture. Viable bacteria were recovered from the CSF of animals infected with E. coli K1 strains only; none of the animals infected with K1- strains had positive CSF cultures. However, despite the fact that their cultures were sterile, the presence of O18 E. coil was demonstrated immunocytochemically in the brains of animals infected with K1- strains and was seen by staining of CSF samples. In vitro, brain microvascular endothelial cells (BMEC) were incubated with K1+ and K1- E. coli strains. The recovery of viable intracellular organisms of the K1+ strain was significantly higher than that for the K1- strain (P = 0.0005). The recovery of viable intracellular K1- E. coli bacteria was increased by cycloheximide treatment of BMEC (P = 0.0059) but was not affected by nitric oxide synthase inhibitors or oxygen radical scavengers. We conclude that the K1 capsule is not necessary for the invasion of bacteria into brain endothelial cells but is responsible for helping to maintain bacterial viability during invasion of the blood-brain barrier.",
author = "Hoffman, {Jill A.} and Carol Wass and Monique Stins and Kim, {Kwang Sik}",
year = "1999",
language = "English (US)",
volume = "67",
pages = "3566--3570",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier

AU - Hoffman, Jill A.

AU - Wass, Carol

AU - Stins, Monique

AU - Kim, Kwang Sik

PY - 1999

Y1 - 1999

N2 - The vast majority of cases of gram-negative meningitis in neonates are caused by K1-encapsulated Escherichia coli. The role of the K1 capsule in the pathogenesis of E. coli meningitis was examined with an in vivo model of experimental hematogenous E. coli K1 meningitis and an in vitro model of the blood-brain barrier. Bacteremia was induced in neonatal rats with the E. coil K1 strain C5 (O18:K1) or its K1- derivative, C5ME. Subsequently, blood and cerebrospinal fluid (CSF) were obtained for culture. Viable bacteria were recovered from the CSF of animals infected with E. coli K1 strains only; none of the animals infected with K1- strains had positive CSF cultures. However, despite the fact that their cultures were sterile, the presence of O18 E. coil was demonstrated immunocytochemically in the brains of animals infected with K1- strains and was seen by staining of CSF samples. In vitro, brain microvascular endothelial cells (BMEC) were incubated with K1+ and K1- E. coli strains. The recovery of viable intracellular organisms of the K1+ strain was significantly higher than that for the K1- strain (P = 0.0005). The recovery of viable intracellular K1- E. coli bacteria was increased by cycloheximide treatment of BMEC (P = 0.0059) but was not affected by nitric oxide synthase inhibitors or oxygen radical scavengers. We conclude that the K1 capsule is not necessary for the invasion of bacteria into brain endothelial cells but is responsible for helping to maintain bacterial viability during invasion of the blood-brain barrier.

AB - The vast majority of cases of gram-negative meningitis in neonates are caused by K1-encapsulated Escherichia coli. The role of the K1 capsule in the pathogenesis of E. coli meningitis was examined with an in vivo model of experimental hematogenous E. coli K1 meningitis and an in vitro model of the blood-brain barrier. Bacteremia was induced in neonatal rats with the E. coil K1 strain C5 (O18:K1) or its K1- derivative, C5ME. Subsequently, blood and cerebrospinal fluid (CSF) were obtained for culture. Viable bacteria were recovered from the CSF of animals infected with E. coli K1 strains only; none of the animals infected with K1- strains had positive CSF cultures. However, despite the fact that their cultures were sterile, the presence of O18 E. coil was demonstrated immunocytochemically in the brains of animals infected with K1- strains and was seen by staining of CSF samples. In vitro, brain microvascular endothelial cells (BMEC) were incubated with K1+ and K1- E. coli strains. The recovery of viable intracellular organisms of the K1+ strain was significantly higher than that for the K1- strain (P = 0.0005). The recovery of viable intracellular K1- E. coli bacteria was increased by cycloheximide treatment of BMEC (P = 0.0059) but was not affected by nitric oxide synthase inhibitors or oxygen radical scavengers. We conclude that the K1 capsule is not necessary for the invasion of bacteria into brain endothelial cells but is responsible for helping to maintain bacterial viability during invasion of the blood-brain barrier.

UR - http://www.scopus.com/inward/record.url?scp=0033005681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033005681&partnerID=8YFLogxK

M3 - Article

C2 - 10377140

AN - SCOPUS:0033005681

VL - 67

SP - 3566

EP - 3570

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 7

ER -